Redi Health operates a mobile and web platform that integrates health management technology with pharmaceutical manufacturer support to connect Pharma, Providers, and Patients on a single platform. The platform provides medication reminders, symptom management, educational resources, and real-time information exchange. Redi positions its product as a solution to high non-adherence rates (approximately 70%) that contribute to substantial industry losses. The company said it will use the new capital to foster innovation, develop and launch new products, further expand its patient network, and accelerate growth. Management framed the funding as a way to improve patient health outcomes and make comprehensive care accessible to millions across the country. Redi.Health is a Columbus, OH-based provider of a health management technology platform that helps patients with chronic conditions understand, manage, and track their total health. Its platform combines health management technology with pharmaceutical manufacturer support and includes a mobile app that lets patients manage multiple medications, symptoms, diet, and exercise. The company has signed partnerships with GoodRx and ScriptDrop and is collaborating with Labcorp to integrate Labcorp Drug Development Patient Access Solutions into its digital support platform. Led by CEO Luke Buchanan, Redi.Health plans to use growth funding to expand its business reach and accelerate product and patient-outcome advancements in 2023. The article reports the company secured growth funding of an undisclosed amount and does not disclose operating metrics or further financial details. Redi.Health builds a health management platform for polychronic patients, combining daily health-management tools, connections to pharmaceutical manufacturer support, and AI-driven health literacy. The product is designed to improve medication adherence and overall quality of life for patients with three or more chronic conditions. Redi.Health provides a single, patient-centric pathway for pharma companies, hubs, and specialty pharmacies to support and engage patients digitally. The company emphasizes simplified tools and novel connectivity to resources patients otherwise might not access. Founded in 2021 and based in Columbus, Ohio, Redi.Health plans to accelerate commercialization and broaden availability of its platform.

Total raised

$14M

Funding rounds

3

Latest round

Series B

Latest activity

Feb 2024